YU24501A - Esters of(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-4fluorophenyl) ethyl)-4-piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907 - Google Patents

Esters of(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-4fluorophenyl) ethyl)-4-piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907

Info

Publication number
YU24501A
YU24501A YU24501A YU24501A YU24501A YU 24501 A YU24501 A YU 24501A YU 24501 A YU24501 A YU 24501A YU 24501 A YU24501 A YU 24501A YU 24501 A YU24501 A YU 24501A
Authority
YU
Yugoslavia
Prior art keywords
esters
piperidinemethanol
dimethoxyphenyl
ethyl
prodrugs
Prior art date
Application number
YU24501A
Other languages
Serbo-Croatian (sh)
Inventor
Albert Carr
Hijfte Luc E. Van
Raymond W. Kosley Jr.
Original Assignee
Aventis Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc. filed Critical Aventis Pharmaceuticals Inc.
Priority to YU24501A priority Critical patent/YU24501A/en
Publication of YU24501A publication Critical patent/YU24501A/en

Links

Landscapes

  • Hydrogenated Pyridines (AREA)

Abstract

The present invention is directed to esters of (+)-α-(2,3-Dimethoxyphenyl)-1-[2-(4-lorophenyl)ethyl] -4-piperidinemethanol, of formula (I) wherein R is C4-C20alkyl, pharmaceutical formulations, methods of making and methods of using these esters. These compounds antagonize the effects of serotonin at the 5HT2A receptor and are useful in treating various conditions such as, for example, psychoses such as schizophrenia.
YU24501A 1998-10-14 1998-10-14 Esters of(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-4fluorophenyl) ethyl)-4-piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907 YU24501A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU24501A YU24501A (en) 1998-10-14 1998-10-14 Esters of(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-4fluorophenyl) ethyl)-4-piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU24501A YU24501A (en) 1998-10-14 1998-10-14 Esters of(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-4fluorophenyl) ethyl)-4-piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907

Publications (1)

Publication Number Publication Date
YU24501A true YU24501A (en) 2003-10-31

Family

ID=47720198

Family Applications (1)

Application Number Title Priority Date Filing Date
YU24501A YU24501A (en) 1998-10-14 1998-10-14 Esters of(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-4fluorophenyl) ethyl)-4-piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907

Country Status (1)

Country Link
YU (1) YU24501A (en)

Similar Documents

Publication Publication Date Title
HUT74992A (en) Use of serotonin antagonist indol derivatives for producing pharmaceutical compositions using for treating fibromyalgia
EA200100553A1 (en) SUBSTITUTED BICYCLIC DERIVATIVES, USEFUL AS ANTICATIVE AGENTS
UA39168C2 (en) Fluoroalkoxyphenyl derivatives of pyperidine or quinuclidine AS antagonists of P substance and pharmaceutical composition based thereon
BG103195A (en) Substituted indazole derivatives and their application as inhibitors of phosphodiesterase (pde) type iv and of the production of a tumournecrotic factor (tnf)
IL133988A0 (en) Indole derivatives as mcp-1 receptor antagonists
ATE187963T1 (en) NEW 4-PIPERIDINYL SUBSTITUTED LACTAME AS A NEW CHOCINE 2 RECEPTOR ANTAGONIST FOR THE TREATMENT OF ASTHMA
IL114599A0 (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them
ES2160525A1 (en) 4-aroyl-piperidin-ccr-3 receptor antagonists iii
IL174678A0 (en) Arylindenophyridines and arylindenophyrimidines and their use as adenosine a2a receptor antagonist
NO963731L (en) Treatment of obsessive-compulsive diseases with 5HT2 antagonists
ES2087038A1 (en) Novel piperidine derivatives with paf antagonist activity
MY140835A (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
NO984740L (en) Isatin derivatives such as acetylcholinesterase inhibitors and analgesics
GR3036639T3 (en) 5-(4-subst.-piperidinyl-1)-3-aryl-pentanoic acid derivatives as tachykinin receptor antagonist
NO963331L (en) 5-Heteroarylindole derivatives as benzodiazepine receptor site agonists and antagonists
GR3032950T3 (en) Substituted fused and bridged bicyclic compounds as therapeutic agents
CA2347469A1 (en) Esters of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 100,907
YU24501A (en) Esters of(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-4fluorophenyl) ethyl)-4-piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907
CA2281702A1 (en) (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
MXPA05011476A (en) Imidazolin-2-ylaminophenyl amides as ip antagonists.
CA2360894A1 (en) (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
UA48962C2 (en) Bicyclic antagonists of tachykinins, pharmaceutical composition and method of treatment
BG105427A (en) Esters of (+)-alpha-(2,3-dimethyloxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pi peridinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 100,907
WO2000037465A3 (en) Novel derivatives of swainsonine, processes for their preparation, and their use as therapeutic agents
ES2141671A1 (en) Pyrimidine compound active on the central nervous system, process for preparing it and pharmaceutical compositions containing it.